INT191341

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.34
First Reported 2006
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 1.66
Pain Relevance 0.64

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell proliferation (TSPO) mitochondrion (TSPO) aging (TSPO)
response to stress (TSPO)
TSPO (Homo sapiens)
Pain Link Frequency Relevance Heat
Paracetamol 7 99.34 Very High Very High Very High
diclofenac 12 98.60 Very High Very High Very High
cINOD 5 97.08 Very High Very High Very High
Analgesic 4 96.52 Very High Very High Very High
carbamazepine 8 85.04 High High
Pain 29 62.00 Quite High
visual analogue scale 10 61.04 Quite High
Pain score 7 55.12 Quite High
c fibre 11 48.56 Quite Low
unmyelinated 6 48.20 Quite Low
Disease Link Frequency Relevance Heat
Bladder Disease 34 100.00 Very High Very High Very High
INFLAMMATION 12 96.96 Very High Very High Very High
Apoptosis 5 93.72 High High
Ulcers 2 89.12 High High
Adenocarcinoma 53 84.00 Quite High
Malignant Neoplastic Disease 5 75.72 Quite High
Cancer 63 70.52 Quite High
Pain 23 62.00 Quite High
Metastasis 2 28.80 Quite Low
Overactive Bladder 26 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Fig. 1Removal, during MBR and CAS treatment, of the analgesics and anti-inflammatory drugs naproxen (a), ketoprofen (b), ibuprofen (c), mefenamic acid (d), diclofenac (e), indomethacin (f), acetaminophen (g), and propyphenazone (h)Fig. 2Removal during MBR and CAS treatment of the antibiotics ofloxacin (a), sulfamethoxazole (b), and erythromycin (c), the ?
Negative_regulation (2Removal) of Gene_expression (treatment) of MBR associated with paracetamol, inflammation, analgesic, cinod and diclofenac
1) Confidence 0.34 Published 2006 Journal Anal Bioanal Chem Section Body Doc Link PMC1805043 Disease Relevance 0.24 Pain Relevance 0.49
Compared to controls, a three- and five-fold increase of TRPM8-immunoreactive axons was seen in IDO and PBS groups respectively.
Negative_regulation (seen) of Gene_expression (groups) of PBS associated with bladder disease
2) Confidence 0.06 Published 2006 Journal BMC Urol Section Body Doc Link PMC1420318 Disease Relevance 0.73 Pain Relevance 0.15
CAM were loaded with: 1 µl PBS (negative control); 1 µl PBS with 250 ng VEGF (R&D Systems, Abingdon, UK) as positive control; 1 µl of medium from Calu6/?
Negative_regulation (positive) of Gene_expression (control) of PBS
3) Confidence 0.02 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2702099 Disease Relevance 0.69 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox